Applied Clinical Trials Speaks with Matrix Clinical Trials President Thad Wolfram on His Experience Leveraging Decentralization Methodologies to Increase Clinical Trial Diversity Inclusion

While historically trial sponsors have leveraged more traditional methods like engaging advocacy groups, the pandemic fueled clinical trial decentralization and showed the benefits of meeting trial participants where they are through in-home, virtual, and Mobile Health Clinic visits.

Applied Clinical Trials recently spoke with Matrix Clinical Trials President Thad Wolfram on his experience leveraging decentralization methodologies to increase clinical trial diversity and inclusion. Matrix Clinical Trials is shifting the paradigm and recognizing that a clinical trial takes place 24 hours a day, seven days a week, wherever the trial participant is.